222 related articles for article (PubMed ID: 35853202)
1. The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.
Wang Z; Su J; Gong F; Xue L; Su Z
J Cardiovasc Pharmacol; 2022 Sep; 80(3):407-416. PubMed ID: 35853202
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of efferocytosis in atherosclerosis.
Shu LX; Cao LL; Guo X; Wang ZB; Wang SZ
J Mol Med (Berl); 2024 Jul; 102(7):831-840. PubMed ID: 38727748
[TBL] [Abstract][Full Text] [Related]
3. The Role of Efferocytosis in Atherosclerosis.
Kojima Y; Weissman IL; Leeper NJ
Circulation; 2017 Jan; 135(5):476-489. PubMed ID: 28137963
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic cell death and efferocytosis in atherosclerosis.
Van Vré EA; Ait-Oufella H; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):887-93. PubMed ID: 22328779
[TBL] [Abstract][Full Text] [Related]
5. Constructing Mal-Efferocytic Macrophage Model and Its Atherosclerotic Spheroids and Rat Model for Therapeutic Evaluation.
Zou D; Yang P; Liu J; Dai F; Xiao Y; Zhao A; Huang N
Adv Biol (Weinh); 2023 Jun; 7(6):e2200277. PubMed ID: 36721069
[TBL] [Abstract][Full Text] [Related]
6. Macrophage death in atherosclerosis: potential role in calcification.
Neels JG; Gollentz C; Chinetti G
Front Immunol; 2023; 14():1215612. PubMed ID: 37469518
[TBL] [Abstract][Full Text] [Related]
7. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
8. Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.
Tajbakhsh A; Rezaee M; Kovanen PT; Sahebkar A
Pharmacol Ther; 2018 Aug; 188():12-25. PubMed ID: 29444453
[TBL] [Abstract][Full Text] [Related]
9. Sonodynamic Therapy Promotes Efferocytosis via CD47 Down-Regulation in Advanced Atherosclerotic Plaque.
Cao Y; Yao J; Gao W; Cao Z; Diabakte K; Wang L; Sun X; Tian Y
Int Heart J; 2022 Jan; 63(1):131-140. PubMed ID: 35034916
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
Thorp E; Tabas I
J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
[TBL] [Abstract][Full Text] [Related]
11. Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs.
Tajbakhsh A; Bianconi V; Pirro M; Gheibi Hayat SM; Johnston TP; Sahebkar A
Trends Endocrinol Metab; 2019 Sep; 30(9):672-683. PubMed ID: 31383556
[TBL] [Abstract][Full Text] [Related]
12. Novel insight on the role of Macrophages in atherosclerosis: Focus on polarization, apoptosis and efferocytosis.
Xie Y; Chen H; Qu P; Qiao X; Guo L; Liu L
Int Immunopharmacol; 2022 Dec; 113(Pt A):109260. PubMed ID: 36252496
[TBL] [Abstract][Full Text] [Related]
13. Assessing Efferocytosis in Atherosclerotic Lesions In Situ.
Yurdagul A
Methods Mol Biol; 2022; 2419():561-567. PubMed ID: 35237988
[TBL] [Abstract][Full Text] [Related]
14. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
[TBL] [Abstract][Full Text] [Related]
15. Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis.
Wang L; Li H; Tang Y; Yao P
Front Endocrinol (Lausanne); 2020; 11():585285. PubMed ID: 33597922
[TBL] [Abstract][Full Text] [Related]
16. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
[TBL] [Abstract][Full Text] [Related]
17. Dead cell and debris clearance in the atherosclerotic plaque: Mechanisms and therapeutic opportunities to promote inflammation resolution.
Dhawan UK; Singhal A; Subramanian M
Pharmacol Res; 2021 Aug; 170():105699. PubMed ID: 34087352
[TBL] [Abstract][Full Text] [Related]
18. Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade.
Wang Y; Nanda V; Direnzo D; Ye J; Xiao S; Kojima Y; Howe KL; Jarr KU; Flores AM; Tsantilas P; Tsao N; Rao A; Newman AAC; Eberhard AV; Priest JR; Ruusalepp A; Pasterkamp G; Maegdefessel L; Miller CL; Lind L; Koplev S; Björkegren JLM; Owens GK; Ingelsson E; Weissman IL; Leeper NJ
Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15818-15826. PubMed ID: 32541024
[TBL] [Abstract][Full Text] [Related]
19. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet.
Li S; Sun Y; Liang CP; Thorp EB; Han S; Jehle AW; Saraswathi V; Pridgen B; Kanter JE; Li R; Welch CL; Hasty AH; Bornfeldt KE; Breslow JL; Tabas I; Tall AR
Circ Res; 2009 Nov; 105(11):1072-82. PubMed ID: 19834009
[TBL] [Abstract][Full Text] [Related]
20. ERK5 activation in macrophages promotes efferocytosis and inhibits atherosclerosis.
Heo KS; Cushman HJ; Akaike M; Woo CH; Wang X; Qiu X; Fujiwara K; Abe J
Circulation; 2014 Jul; 130(2):180-91. PubMed ID: 25001623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
